Article | January 11, 2022

Good Clinical Practices And 5 Common GCP Violations In Clinical Studies

By Michelle Sceppa

doctor meeting clinical iStock-846002754

Good Clinical Practices (GCPs) provide a platform for the quality of the data and a unified standard for the conduct of clinical trials. In a clinical study, all data must be recorded, handled, and stored properly. Confidentiality of subject records must be maintained in accordance with applicable regulatory requirements. Patient rights, safety, and well-being are of primary concern. Foreseeable risks and inconveniences should be weighed against anticipated benefit. Clinical trials should be scientifically sound and clearly described in the study protocol. The clinical trial should be conducted in compliance with the study protocol.

The protection of the rights of subjects and the safety of the subjects is paramount. This can be obtained by thorough oversight by the sponsor, meticulous documentation. Here we review what GCPs require of a clinical study, the regulatory requirements, and the most common issues cited in FDA inspections of clinical trials.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader